Nexvax2 is an experimental vaccine for celiac disease being developed under the lead of Dr. Anderson at ImmusanT. They’re still experimenting with safety and tolerability, so no data is available on efficacy. That said, it’s true that the vaccine is designed to work in persons with celiac disease carrying HLA-DQ2, which is the most common gene for the disease. June, 2017